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Trend and Outcome of Korean Patients Receiving Overseas Solid 
Organ Transplantation between 1999 and 2005
The disparity between patients awaiting transplantation and available organs forced many 
patients to go overseas to receive a transplant. Few data concerning overseas 
transplantation in Korea are available and the Korea Society for Transplantation conducted 
a survey to evaluate the trend and outcome of overseas transplantation. The survey, 
conducted on June 2006, included 25 hospitals nationwide that followed up patients after 
receiving kidney transplant (KT) or liver transplant (LT) overseas. The number of KT increased 
from 6 in 2001 to 206 in 2005 and for LT from 1 to 261. The information about overseas 
transplant came mostly from other patients (57%). The mean cost for KT was $21,000 and 
for LT $47,000. Patients were admitted for 18.5 days for KT and 43.4 days for LT. Graft 
and patient survival was 96.8% and 96.5% for KT (median follow up 23.1 months). 
Complication occurred in 42.5% including surgical complication (5.3%), acute rejection 
(9.7%) and infection (21.5%). Patient survival for LT was 91.8% (median follow up 21.2 
months). Complication occurred in 44.7% including 19.4% biliary complication. Overseas 
KT and LT increased rapidly from 2001 to 2005. Survival of patients and grafts was 
comparable to domestic organ transplantation, but had a high complication rate.
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ORIGINAL ARTICLE
Cell Therapy & Organ Transplantation
INTRODUCTION
The development of organ transplantation (OT) has prolonged 
and improved the lives of thousands of patients worldwide. How-
ever, these outstanding accomplishments have been tarnished 
by the numerous reports about organ trafficking using under-
privileged human beings as sources of organs for more prosper-
ous and wealthy patients. (1). At the Second Global Consultation 
on Human Transplantation of the World Health Organization 
(WHO) in March 2007, it was estimated that organ trafficking 
accounts for 5%-10% of the kidney transplants (KT) performed 
annually throughout the world (2). There have been various re-
ports that OT is performed not only in underdeveloped or de-
veloping countries such as Pakistan, Iran, the Philippines, India, 
Mainland China, Eastern Europe, South America or South Afri-
ca, but also in developed countries such as Belgium, Germany, 
and Italy (3-7). Even in the United States, because the access to 
brain death donors is easier than most underdeveloped coun-
tries, wealthy patients from underdeveloped countries come to 
the US to receive OT (3, 5).
  This is no exception in Korea. Overseas OT first began in 1999 
where a patient went to Mainland China to receive a KT and 2001 
for LT. However, there has been no data concerning the magni-
tude and trend of OT nationwide except for sporadic reports from 
single centers (8, 9). The Korean Society for Transplantation has 
therefore conducted a nationwide survey to evaluate the trend 
and outcome of overseas OT in Korea. 
MATERIALS AND METHODS
The survey was conducted in June 2006. A list of patient ques-
tionnaires was sent to all of the hospitals that had followed up 
patients after receiving OT overseas. It included 25 hospitals for 
KT and 13 hospitals for LT. The questionnaire included access 
to information of overseas OT center, expense (operation cost 
and total expense), duration of hospitalization, complications 
during follow up period, graft survival, patient survival, and 
cause of death. The questionnaires were filled in by the medical 
staff members. 
RESULTS
The questionnaire included 462 patients that received KT and 
504 patients that received LT. All the patients received OT from 
Mainland China. KT was performed in 28 centers and LT in 5 
centers nationwide.Kwon CHD, et al.  •  Overseas Solid Organ Transplantation of Korean Patients
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Access to information of overseas OT center 
Most of the information about overseas OT center came from 
other patients (57%). Other 43% of the patients obtained infor-
mation from a friend or known persons. About 4% of the patients 
got the information from the doctor and 3% from the internet, 
which was surprisingly low since according to the investigation 
done by the author in year 2006, there was about 1,700 users in 
14 internet homepages concerning overseas OT in Korea. An-
other 8% of the patients were informed by Chinese brokers.
Expense and hospital stay
The mean operation fee to get a KT was US$21,000 (US$15,000-
US$46,000), and another US$21,000 (US$15,000-US$32,000) was 
necessary for other expense during the stay. The mean hospital 
stay was 18.5 days ranging from 14 to 90 days. 
  For LT the needed expense was about twice of KT; the opera-
tion fee was US$47,000 (US$41,000-US$160,000), and extra ex-
pense of US$16,000 (US$8,600-US$25,000) was necessary dur-
ing the stay. The mean hospital stay was 43.4 days (range 7-84 
days) which was also twice longer than KT.
Annual trend of overseas OT
The number of OT overseas performed annually is shown in 
Figs. 1, 2. Until 2001, only 6 cases of KT was performed which 
increased each year reaching 206 cases in the year 2005. In 2001, 
overseas KT constituted only 1% of the total annual KT cases 
performed in Korea but by year 2005, it included 21.2%. In com-
parison to the rapid increase of overseas KT, the number of de-
ceased donor KT has not increased much during 2001 and 2005 
and by 2005, the fraction of KT operated overseas has surpassed 
the proportion of deceased donor KT (17.0% in 2001 and 17.8% 
in 2005). Total of 434 cases of overseas KT has been done by 2005 
since the first KT in 1999 (Fig. 1). In comparison to KT, there was 
only one simultaneous pancreas-kidney transplantation per-
formed annually from 2002 to 2004, and there was none in 2005. 
  The first case of overseas LT was done in 2001, with an expo-
nential increase every year reaching 261 cases by the year 2005. 
In 2005, overseas LT constituted for 30.5% of total annual LT cases 
in Korea, and was almost four times the number of deceased 
donor LT. There has been a total of 490 cumulative LT cases until 
2005 and the number has outrun the number of KT since 2004 
(Fig. 2).
Clinical outcome of KT
Due to the nature of data acquisition, detailed description of 
each patient was not available and the exact patient and graft 
survival was not possible to obtain. Nevertheless, with a medi-
an follow up of 23.1 months, death-censored graft survival was 
96.8%, and patient survival was 96.5%. Fifteen patients died (mor-
tality rate 3.5%). Infection was the most common cause of death 
(sepsis in 4, necrotizing fasciitis 1, aspergillosis 1), and intracra-
nial hemorrhage occurred in 1 patients. The cause of death of 
remaining 8 patients was not described and could not be evalu-
ated. 
  Complication rate was 42.5%. The most frequent complica-
tion was infection which accounted for 21.5%, followed by acute 
rejection 9.7% and surgical complication 5.3%. Cytomegalovirus 
infection developed in 4.8%, pneumonia in 4.6%, urinary tract 
infection in 3.9%, wound infection in 3.7%, herpes zoster in 2.1%, 
BK virus nephropathy in 2.1%, and pyelonephritis in 0.2%. The 
type of pneumonia was bacterial pneumonia 1.6%, tuberculosis 
1.6%, and Pneumocystis carinii pneumonia 1.4%. Ureterovesci-
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Fig. 1. Annual number of kidney transplantation reported in Korea. The proportion of 
domestic deceased donor, domestic living donor and overseas kidney transplantation 
is shown. The proportion of domestic deceased donor kidney transplantation has not 
changed over time (from 17.0% to 17.8%) while overseas transplantation has increased 
abruptly since 2002. Deceased (    ), living (    ), and overseas (    ) kidney transplantation.
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Fig. 2. Annual number of liver transplantation reported in Korea. Overseas domestic 
deceased donor, domestic living donor and overseas liver transplantation is shown. 
Overseas transplantation has increased exponentially since 2002. Deceased (    ), living 
(    ), and overseas (    ) liver transplantation.
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cal anastomosis leakage occurred in 2.1%, hydronephrosis in 
1.2%, vascular complication in 0.9%, lymphocele in 0.7% and 
ureterovescical reflux in 0.5% (Table 1). 
Clinical outcome of LT
The most common cause of LT was hepatitis B related liver cir-
rhosis (62.8%), followed by hepatitis B related hepatocellular 
carcinoma (22.4%), hepatitis C related liver cirrhosis (4.7%), and 
retransplantation (2.1%). Other causes including alcoholic liver 
cirrhosis, autoimmune hepatitis consisted of 8.3%. Hepatitis B 
related liver disease was the etiology in 85.2% which is a relative-
ly similar distribution to the LT done within Korea.
  With a median follow up of 21.2 months, patient survival was 
91.8%. This percentage does not represents overall patient sur-
vival of LT, but only of patients who could return to Korea to be 
followed up. Among the 40 patients that died (mortality rate 
8.2%), the cause of death was describe in only 26; hepatocellu-
lar carcinoma recurrence 11, sepsis 9, hepatitis virus (either B 
or C) recurrence 3, and intracranial hemorrhage 3.
  Complication developed in 44.7%. Biliary complication was 
the most common cause 19.4%, followed by hepatocellular car-
cinoma recurrence 7.8%, hepatitis B or C recurrence 6.5%, bac-
terial infection 4.9%, vascular complication 4.3%, and acute re-
jection 1.8%. Other complications such as wound infection, in-
cisional hernia, graft versus host disease and bleeding consisted 
of 15.6% (Table 2).
DISCUSSION 
OT prolongs life and improves life quality of patients with end 
stage organ failure and is regarded as the treatment option. How-
ever, due to the discrepancy between patients willing to get a 
transplant and the donors available, many patients die while 
waiting for an organ. According to the Korean Network for Or-
gan Sharing (KONOS), the number of patients in the KT waiting 
list reached 7,641 by 2008, but only 481 patients (one out of 15) 
received a deceased donor KT. Patients in the LT waiting list was 
2,596, but only 481 patients got deceased donor LT (10). In coun-
tries such as Korea, where brain death donation is not active, in 
order to meet the demands of organs, living donor OT is per-
formed as an alternative. Living donor KT accounted for 59.8% 
and living donor LT 78.9% of all OT performed in 2008 (10). As 
a result, when a suitable living donor was not available, patients 
had to turn their eyes on getting an OT overseas.
  Medical tourism for OT usually occurs in countries where do-
nors are readily accessible. Although OT by means of organ traf-
ficking are usually done in less developed countries, medical 
tourism is not an issue of ‘underdeveloped’ countries only. It is 
estimated that about 0.8% of KT recipients and 1.5% of LT recip-
ients in the USA are of foreigners, which implies that many for-
eign patients enter to the USA to ‘purchase’ an organ (3, 5). For-
eign patients can legally receive deceased donor OT in Korea, 
but due to the scarcity of available deceased donors, ‘purchase’ 
of deceased donor organ is rather unrealistic. According to the 
KONOS data (personal communication) all foreigners that un-
derwent OT in Korea used living donors. Organ trafficking is 
strictly forbidden in Korea and all living donor OT must receive 
permission from KONOS, where thorough investigation of fa-
milial relationship is done, to carry out OT.
  All the overseas OT in Korea from our data was done in Main-
land China. The main ethical issue is that most of the organ do-
nors in Mainland China come from executed prisoners. Accord-
ing to the Chinese Deputy Minister of Health, Huang Jiefu, ap-
proximately 95% of all organs used for transplantation are from 
executed prisoners and it is estimated that about 10% are used 
in organ trafficking (2, 11). On October 2007 the Chinese Medi-
cal Association agreed on a moratorium of commercial organ 
harvesting from condemned prisoners, and agreed to restrict 
transplantations from donors to their immediate relatives (12, 
13). Since the survey was conducted between 2000 and 2005, 
the increase of overseas OT reflects the increase of organ traffick-
ing within China. Further data of overseas OT will be necessary 
Table 1. Complications of overseas kidney transplant recipients
Complications 42.5%
Infection 21.5%
CMV infection   4.8%
UTI   3.9%
Wound infection   3.7%
BK nephropathy   2.1%
Herpes Zoster   2.1%
Tuberculosis   1.6%
Pneumonia   1.6%
Pneumocystis Carinii Pneumonia   1.4%
Pyelonephritis   0.2%
Acute rejection   9.7%
Surgical Complication   5.3%
Anastomosis leak   2.1%
Hydronephrosis   1.2%
Vascular complication   0.9%
Lymphocele   0.7%
Ureterovesical reflux   0.5%
Others    6.0%
CMV, cytomegalovirus; UTI, urinary tract infection.
Table 2. Complications of overseas liver transplant recipients
Complications 44.7%
Biliary complications 19.4%
HCC recur   7.8%
HBV/HCV infection   6.5%
Infection   4.9%
Vascular complications   4.3%
Acute rejection   1.8%
HCC, hepatocellular carcinoma; HBV, hepatitis B virus; HCV, hepatitis C virus.Kwon CHD, et al.  •  Overseas Solid Organ Transplantation of Korean Patients
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to evaluate the impact of the moratorium.
  However, the issue of overseas OT does not lie solely on ethi-
cal issues but also medical. According to Kennedy and collea-
gues, 5 patient of 16 died during the course of overseas KT, and 
concluded that the patient and graft survival were worse than 
KT within Australia (4). Similar concern was raised concerning 
LT, where 1 and 5 yr survival rate was lower among overseas LT 
recipients (90% and 77% vs 93% and 93%) (14). On the other 
hand, others have reported that overseas OT had similar results 
(15-17). Our results show that patient and graft survival of both 
KT and LT recipients are comparable to that of domestic KT and 
LT recipients. Mortality rate for KT was 3.5% at 23.1 months me-
dian follow up and 8.2% for LT at 21.2 months. Nevertheless, it 
should be stressed that these results were based only on patients 
who return home excluding in hospital mortality and not of all 
the patients that went abroad. Shibolet and collegues reported 
that in spite of successful transportation overseas by precautious 
measures taken during long-distance transportation, a mortali-
ty rate of 30.2% occurred in patients while waiting for LT or fol-
lowing LT overseas (6). Therefore we cannot draw any conclu-
sions on whether the overall patient and graft mortality of over-
seas OT was really ‘comparable’ .
  Concern of higher complication rate is another issue. Algham-
di reported that overseas KT patients had a higher percentage 
of acute rejection compared to the patients transplanted within 
Saudi Arabia (27.9% vs 9.9%, P = 0.005) (17). Others have de-
scribed a higher rate of fungal, CMV, HIV, or hepatitis B or C in-
fection, or urological complication among overseas KT recipi-
ents (4, 9, 15-18). According to our data, KT recipients experi-
enced a relatively high postoperative complication rate of 42.5%, 
with infection as the most common cause. However, surgical 
complication and acute rejection rate was relatively low (5.3% 
and 9.7%). 
  The complication rate of LT reached 44.7%, with 19.7% biliary 
complication as the most common etiology. Although not much 
is known about the quality and nature of the donor liver, wheth-
er it is a brain death or cardiac death donor, the complication 
rate of biliary complication is higher compared to orthotopic LT 
using brain death donors which is reported to be 5%-15% (19) 
and lower compared to cardiac death donors which is reported 
to be around 30% (20). 
  De novo infection of hepatitis B or C is also another major 
problem. It is essential to get sufficient information about the 
donor as well as the recipients before and after LT, and failure to 
do so may result in detrimental consequences for the recipient. 
A major drawback to resolving this issue is that most of the LT 
performed overseas are associated with organ trafficking most-
ly done ‘undercover’ (15).
  The wide discrepancy between available donors and recipi-
ents on the waiting list has forced many patients to involuntarily 
choose overseas organ transplantation. This has not only posed 
ethical problems, since most of the donors are from executed 
prisoners, but also medical concerns due to lack of communi-
cation between centers and information about the donors and 
recipients. Efforts to better communicate patient information 
should be made to enhance the postoperative care of patients 
whom otherwise may not receive the proper medical care after 
returning home. Moreover, to resolve the current discouraging 
experience we must push forward to expanding the donor pool 
more aggressively. The exponential growth of overseas OT, along 
with the ethical and medical problems underlying the process, 
became an important social issue in Korea since 2003, and these 
events highlighted the importance of increasing the donor pool 
and helped soften the social and cultural attitude towards do-
nation after death, which like in many other Asian countries, 
has been an important drawback in increasing the donor pool. 
Together with much effort of both the medical as well as social 
and legal community, the number of deceased donors has in-
creased from 91 in 2005 to 261 in 2009, and a new law on OT has 
been passed on May 2010 to boost donor action program (10). 
It is therefore important to bring out these issues openly to help 
rebuild a better system and try to achieve self sufficiency as em-
phasized by WHO (21).  
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